Are you having problems with your bladder? There may be a more profound cause for the suffering than a random nuisance. The ...

For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

Frequent urination often signals underlying health conditions that require medical attention. While occasional increases in ...

There is a wide range of variability with how often one should pee, particularly in regard to what’s “normal.” Learn if you ...

Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...

Oct. 15, 2024 — A team tests the protective effect of a fermented black garlic extract against inflammation and the progression of prostate cancer in a study conducted on human prostate cancer ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...

It is clearly effective in increasing bladder capacity, but the impacts on bedwetting are less certain with mixed results in research studies. It might be a useful adjunctive therapy to other ...